Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer

Fig. 2

Dependence of the WID-CIN index in hrHPV-positive control samples on biobank storage time (A). The WID-CIN index in the predictive validation set consisting of hrHPV-positive and cytology-negative samples taken 1–4 years prior to either a diagnosis with CIN3+ (red points) or censoring (blue points) (B). ROC curve corresponding to the predictive validation set (C)

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us